U.S. Securities & Exchange Commission
SEC Seal
Home | Previous Page
U.S. Securities and Exchange Commission

Washington, D.C.

RELEASE NO. 34-42763 / May 8, 2000

The Securities and Exchange Commission announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the "Exchange Act"), of over-the-counter trading of the securities of Asthma Disease Management, Inc. ("ADMI"), of Berlin, New Jersey at 9:30 a.m. EDT on May 8, 2000, and terminating at 11:59 p.m. EDT on May 19, 2000.

The Commission temporarily suspended trading in the securities of ADMI because of questions that have been raised about the accuracy and adequacy of publicly disseminated information concerning, among other things, purported contracts between ADMI and three health maintenance organizations: Cape Health Plan (f/k/a Cape Medical) of Detroit, Michigan; Horizon Mercy of Trenton, New Jersey; and HMA of Philadelphia, Pennsylvania.

The Commission cautions broker-dealers, shareholders, and prospective purchasers that they should carefully consider the foregoing information along with all other currently available information and any information subsequently issued by the company.

Further, brokers and dealers should be alert to the fact that, pursuant to Rule 15c2-11 under the Exchange Act, at the termination of the trading suspension, no quotation may be entered unless and until they have strictly complied with all of the provisions of the rule. If any broker or dealer has any questions as to whether or not he has complied with the rule, he should not enter any quotation but immediately contact the staff of the Securities and Exchange Commission in Washington, D.C. If any broker or dealer is uncertain as to what is required by Rule 15c2-11, he should refrain from entering any quotations relating to ADMI's securities until such time as he has familiarized himself with the rule and is certain that all of its provisions have been met. If any broker or dealer enters any quotation which is in violation of the rule, the Commission will consider the need for prompt enforcement action. If any broker-dealer or other person has information which may relate to this matter, the Philadelphia District Office of the Securities and Exchange Commission should be telephoned at (215) 597-3100.